Table of contents

Special issue articles

• Outcomes and endpoints of relevance in gynecologic cancer clinical trials (6 March, 2023)

  Ainhoa Madariaga, Rodrigo Sanchez-Bayona, Fernanda G Herrera, Pedro T Ramirez, Antonio González Martín
• Update in the molecular classification of endometrial carcinoma (6 March, 2023)

  Alicia Léon-Castillo
• Biomarker-driven therapy in endometrial cancer (6 March, 2023)

  Hannah Karpel, Brian Slomovitz, Robert L Coleman, Bhavana Pothuri
• Immunotherapy in endometrial cancer (6 March, 2023)

  Haider Mahdi, Anca Chelariu-Raicu, Brian M Slomovitz
• Genomic testing in high-grade serous ovarian cancer: current options and future development (6 March, 2023)

  Michael-John Devlin, Rowan Miller
• Overcoming PARP inhibitor resistance in ovarian cancer (6 March, 2023)

  Pamela Soberanis Pina, Stephanie Lheureux
• Novel therapeutics in low-grade serous ovarian cancer (6 March, 2023)

  Lauren Cobb, David Gershenson
• New therapies for clear cell ovarian carcinoma (6 March, 2023)

  James Stewart, Niamh Cunningham, Susana Banerjee
• Updates on cervical cancer prevention (6 March, 2023)

  David Viveros-Carreño, Andreina Fernandes, Rene Pareja
• Advances in immunotherapy in cervical cancer (6 March, 2023)

  Juan-Francisco Grau, Lorena Farinas-Madrid, Carmen Garcia-Duran, David Garcia-Illescas, Ana Oaknin
• Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy (6 March, 2023)

  Lindsay Hennah, Michael Seckl, Ehsan Ghorani
• Integrating antibody drug conjugates in the management of gynecologic cancers (6 March, 2023)

  Anca Chelariu-Raicu, Sven Mahner, Kathleen Nadine Moore, Domenica Lorusso, Robert L Coleman